Figure 2: Analysis of the cytotoxic effect of chemotherapeutic agents on MUG-Myx2a and MUG-Myx2b cells.
From: Establishment of a novel cellular model for myxofibrosarcoma heterogeneity
Both sub-clones were treated with (A) 0–25 μM doxorubicin, (B) 0–25 μM Verinostat, and (C) 0–25 nM Bortezomib and measured after 48 h.
